Home/Filings/4/0001493152-21-017104
4//SEC Filing

Shah Amit B. 4

Accession 0001493152-21-017104

CIK 0000908259other

Filed

Jul 15, 8:00 PM ET

Accepted

Jul 16, 5:37 PM ET

Size

7.2 KB

Accession

0001493152-21-017104

Insider Transaction Report

Form 4
Period: 2021-07-08
Shah Amit B.
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Stock Options

    2021-07-08+698,256698,256 total
    Exercise: $0.16From: 2021-07-08Exp: 2031-07-08Common Stock (698,256 underlying)
  • Award

    Common Stock

    2021-07-08+298,837358,837 total
Footnotes (2)
  • [F1]Shares were issued in settlement of Restricted Stock Units granted pursuant to the Issuer's 2015 Equity Incentive Plan that vested immediately upon grant.
  • [F2]Stock options granted pursuant to the Issuer's 2015 Equity Incentive Plan, which vest immediately on date of grant.

Documents

1 file

Issuer

Oncotelic Therapeutics, Inc.

CIK 0000908259

Entity typeother

Related Parties

1
  • filerCIK 0001719077

Filing Metadata

Form type
4
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 5:37 PM ET
Size
7.2 KB